Chuo-ku, Japan

Hidetoshi Akimoto

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Regimmune Corporation. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hidetoshi Akimoto. Retrieved from https://idiyas.com/inventor/hidetoshi-akimoto-zvvmf99z

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hidetoshi Akimoto: Innovator in Diabetes Treatment

Introduction

Hidetoshi Akimoto is a notable inventor based in Chuo-ku, Japan. He has made significant contributions to the field of diabetes treatment, particularly focusing on type I diabetes. His innovative approach aims to provide effective solutions for individuals affected by this condition.

Latest Patents

Akimoto holds a patent for a preparation designed to prevent or treat type I diabetes. The invention emphasizes a combination of components that significantly alleviate the onset and symptoms of the disease. The preparation includes at least one member selected from proinsulin, insulin, insulin A chain, insulin B chain, fragments, and variants thereof, combined with α-GalCer. This innovative method showcases Akimoto's commitment to advancing medical treatments.

Career Highlights

Hidetoshi Akimoto is associated with Regimmune Corporation, where he continues to develop groundbreaking solutions in the medical field. His work has garnered attention for its potential to improve the quality of life for those suffering from type I diabetes.

Collaborations

Akimoto collaborates with esteemed colleagues, including Omar Duramad and Yasuyuki Ishii, who contribute to his research and development efforts. Their combined expertise enhances the innovative processes at Regimmune Corporation.

Conclusion

Hidetoshi Akimoto's contributions to diabetes treatment through his patent and collaborative efforts highlight his role as a significant innovator in the medical field. His work continues to inspire advancements in the prevention and treatment of type I diabetes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…